Seattle Genetics reported $601.92M in Operating Expenses for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Agios Pharmaceuticals AGIO:US $ 102.18M 13.03M
Bayer BAYN:GR 9.1B 154M
Bluebird Bio BLUE:US $ 137.27M 102.36M
Celldex Therapeutics CLDX:US $ 23.43M 2.76M
Daiichi Sankyo 4568:JP 241.97B 15.05B
Eisai 4523:JP Y 189324M 31365M
Genmab GEN:DC 1.61B 205M
Immunogen IMGN:US $ 60.93M 1.62M
Mirati Therapeutics MRTX:US $ 184.93M 12.45M
Nektar Therapeutics NKTR:US $ 137.92M 598K
Novartis NOVN:VX 10.96B 826M
Spectrum Pharmaceuticals SPPI:US $ 14.06M 22.79M
Teva Pharmaceutical TEVA:IT 4.02B 758M
Xencor XNCR:US $ 59.03M 3.33M